Clinical Trials Directory

Trials / Completed

CompletedNCT07169721

CIRCAdian Rhythm of the IMMune Age IndeX (IMMAX)

CIRCAdian Rhythm of the IMMune Age IndeX (CIRCA-IMMAX) - Influence of Circadian Rhythm on the Determination of an Immune Age Metric

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Leibniz Research Centre for Working Environment and Human Factors · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this observational study is to evaluate the influence of circadian rhythms on the determination of an individual's immune age. The biomarker IMMAX was calculated for 50 participants aged 20-69 at 8 a.m., 1 p.m. and 6 p.m. on the same day.

Conditions

Timeline

Start date
2023-12-01
Primary completion
2024-03-28
Completion
2024-04-22
First posted
2025-09-12
Last updated
2025-09-17

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT07169721. Inclusion in this directory is not an endorsement.